Growth Metrics

MediXall (MDXL) Current Assets (2019 - 2024)

MediXall's Current Assets history spans 8 years, with the latest figure at $46940.0 for Q3 2024.

  • For Q3 2024, Current Assets rose 256.93% year-over-year to $46940.0; the TTM value through Sep 2024 reached $46940.0, up 256.93%, while the annual FY2023 figure was $14205.0, 23.53% up from the prior year.
  • Current Assets reached $46940.0 in Q3 2024 per MDXL's latest filing, up from $43033.0 in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $1.9 million in Q1 2021 to a low of $5773.0 in Q1 2023.
  • Average Current Assets over 5 years is $332484.2, with a median of $84097.0 recorded in 2022.
  • Peak YoY movement for Current Assets: tumbled 97.47% in 2023, then surged 1148.78% in 2024.
  • A 5-year view of Current Assets shows it stood at $1.1 million in 2020, then tumbled by 69.75% to $342945.0 in 2021, then crashed by 96.65% to $11499.0 in 2022, then grew by 23.53% to $14205.0 in 2023, then surged by 230.45% to $46940.0 in 2024.
  • Per Business Quant, the three most recent readings for MDXL's Current Assets are $46940.0 (Q3 2024), $43033.0 (Q2 2024), and $72092.0 (Q1 2024).